Background The blood coagulation cascade was reported to be activated
in patients with arteriosclerotic disease of the lower limbs (peripher
al arterial disease, PAD). There is more thrombin and fibrin formation
compared with healthy control subjects. In many studies, however, the
presence of arteriosclerotic disease had not been thoroughly ruled ou
t in the control group. Therefore, markers of the activation of the bl
ood coagulation cascade were measured in patients with PAD and in a ca
refully defined control group, both groups being subjected to an exerc
ise test. Methods and Results Twenty-two patients with angiographicall
y documented PAD of grade II (Fontaine classification) and 13 control
subjects in whom the presence of arteriosclerotic lesions was ruled ou
t by noninvasive means in the carotid arteries, abdominal aorta, leg a
rteries, and coronary arteries took part in the study. Before and imme
diately after a treadmill stress test, the concentrations of prothromb
in fragment F1+2 (F1+2), thrombin-antithrombin III complexes (TAT), fi
brinopeptide A (FPA; this peptide was measured in spot urine also), an
d D-dimers were measured. Before exercise, the concentrations of F1+2
(1.0+/-0.6 versus 0.7+/-0.3 nmol/L), TAT (2.9+/-2.1 versus 1.9+/-0.8 m
u g/L), and D-dimers (318.2+/-270.1 versus 150.0+/-91.4 mu g/L) were s
ignificantly higher in the patients with PAD compared with the healthy
control subjects. FPA concentrations in plasma (1.9+/-1.0 versus 1.4/-0.6 mu g/L) and spot urine were not different, however. F1+2, FPA, a
nd D-dimer concentrations correlated with the severity of the PAD as a
ssessed by the ankle systolic brood pressure index (ABPI). The symptom
-limited stress test did not lead to further activation of the blood c
oagulation cascade. However, concentrations of F1+2 (P<.001) and TAT (
P<.01) after exercise correlated with the presence of ischemic changes
in the stress-test ECG. Conclusions There is evidence of enhanced thr
ombin formation in patients with PAD compared with an age- and sex-mat
ched control group without clinical and sonographic evidence of arteri
osclerosis. The thrombin formed, however, appears to be almost complet
ely neutralized by antithrombin III. No direct evidence of fibrin form
ation was obtained, since the FPA concentrations were not different. I
n the patients with PAD, the higher concentrations of D-dimers are ind
icative of invivo fibrinolysis. Thus, some fibrin formation must be po
stulated to occur in patients with arteriosclerosis.